Sequoia Fund wins dismissal of lawsuit over huge Valeant stake

Fri Feb 24, 2017 1:34pm EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

By Jonathan Stempel

NEW YORK (Reuters) - A New York state judge has dismissed a lawsuit accusing the Sequoia Fund, known for its ties to Warren Buffett, of recklessly making a huge, disastrous investment in Valeant Pharmaceuticals International Inc (VRX.TO: Quote), causing billions of dollars of losses.

Justice O. Peter Sherwood of the State Supreme Court in White Plains, New York, said Sequoia shareholders failed to show it would have been futile, prior to suing in January 2016, to demand that the mutual fund's directors step in to unwind the investment because of their alleged conflicts of interest.

The judge said the shareholders could try to amend their complaint, but that this appeared to be "a fool's errand."

Sherwood issued his ruling during a Feb. 15 hearing. A transcript was made public eight days later.

Sequoia shareholders had sued Sequoia's investment adviser Ruane, Cunniff & Goldfarb; portfolio managers Robert Goldfarb and David Poppe; and three directors including author and chairman Roger Lowenstein.

The defendants were accused of gross negligence for letting Sequoia plow nearly one-third of its assets into Valeant, despite a policy capping its stake at 25 percent.

Lawyers for the shareholders did not immediately respond to requests for comment on Friday.

Valeant shares have tumbled 93 percent in the last 1-1/2 years amid criticism of the Canadian drug company's pricing and business practices, and regulatory and congressional probes.   Continued...

The headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec in this file picture taken November 9, 2015.   REUTERS/Christinne Muschi/File Photo